Prevalence, patient characteristics and outcomes of a novel piperacillin/tazobactam-resistant, pan-β-lactam-susceptible phenotype in Enterobacteriaceae: implications for selective reporting

Stainton, S. M., Thabit, A. K., Kuti, J. L., Aslanzadeh, J., & Thabit, A. K. (2017, August 1). Prevalence, patient characteristics and outcomes of a novel piperacillin/tazobactam-resistant, pan-β-lactam-susceptible phenotype in Enterobacteriaceae: implications for selective reporting. Clinical Microbiology and Infection. Elsevier B.V. https://doi.org/10.1016/j.cmi.2017.02.012